Nathan Keller - Concepedia

Author

Nathan Keller

Also Known As

Ella Gev, Imad Kasis, Kata Martinova, Keller, Nathan, N Keller, N. KELLER, N. Keller, NATHAN A. KELLER, NATHAN KELLER, Natan Keller

173

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Sheba Medical Center Tel Aviv University Israel Ministry of Health Ariel University Rabin Medical Center

About

Nathan Keller is an author at Sheba Medical Center specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	39	3K
2	Health Sciences	11	12	1.5K
3	Engineering	2	2	159
4	Public Health	2	2	97
5	Allergy	1	1	303

Nathan Keller

Publications

Citations

H-Index

Page 1

	Year	Citations
Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients Raul Colodner, Wasseem Rock, Bibiana Chazan, European Journal of Clinical Microbiology & Infectious Diseases Nonhospitalized PatientsAntimicrobial SusceptibilityKlebsiella PneumoniaeExtended-spectrum Beta-lactamase-producing BacteriaHospital Epidemiology	2004	363
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections Debby Ben-David, R. Kordevani, Nathan Keller, Clinical Microbiology and Infection Health SciencesAntibioticsKlebsiella PneumoniaeMicrobiologyInfection Control	2011	354
Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome Miri Blank, Ilan Krause, Mati Fridkin, Journal of Clinical Investigation InflammationAutoimmune DiseaseAllergyMicrobial PathogensMedicine	2002	303
Clinical Prevalence, Antimicrobial Susceptibility, and Geographic Resistance Patterns of Enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997–1999 Donald E. Low, Nathan Keller, A.L. Barth, Clinical Infectious Diseases Worldwide TrendAntimicrobial ChemotherapyAntibiotic ResistanceBacterial PathogensDrug Resistance	2001	288
Nasopharyngeal Carriage of<i>Streptococcus pneumoniae</i>by Adults and Children in Community and Family Settings Gili Regev‐Yochay, Meir Raz, Ron Dagan, Clinical Infectious Diseases	2004	280
Bacterial induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome Miri Blank, Ilan Krause, Mati Fridkin, Journal of Clinical Investigation Microbial PathogensImmunodeficienciesInnate Immune SystemImmunologyHumoral Response	2002	261
Rhino‐Orbital and Rhino‐Orbito‐Cerebral Mucormycosis Yoav P. Talmi, Anna Goldschmied‐Reouven, Mati Bakon, Otolaryngology	2002	246
Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection Ronen Ben‐Ami, Keren Olshtain‐Pops, Michal Krieger, Antimicrobial Agents and Chemotherapy Recent ExposureFluconazole-resistant Candida IsolatesAntimicrobial ChemotherapyAntibiotic ResistanceDrug Resistance	2012	174
Potential Role of Active Surveillance in the Control of a Hospital-Wide Outbreak of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Infection Debby Ben-David, ‪Yasmin Maor‬‏, Nathan Keller, Infection Control and Hospital Epidemiology	2010	169
Clinical Features of Heteroresistant Vancomycin-Intermediate <i>Staphylococcus aureus</i> Bacteremia versus Those of Methicillin-Resistant <i>S. aureus</i> Bacteremia ‪Yasmin Maor‬‏, Michal Hagin, Natasha Belausov, The Journal of Infectious Diseases	2009	163

Page 1